Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Sex Transm Infect ; 89(6): 460-6, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23903808

RESUMO

OBJECTIVES: Complex interactions of vaginal microorganisms with the genital tract epithelium shape mucosal innate immunity, which holds the key to sexual and reproductive health. Bacterial vaginosis (BV), a microbiome-disturbance syndrome prevalent in reproductive-age women, occurs commonly in concert with trichomoniasis, and both are associated with increased risk of adverse reproductive outcomes and viral infections, largely attributable to inflammation. To investigate the causative relationships among inflammation, BV and trichomoniasis, we established a model of human cervicovaginal epithelial cells colonised by vaginal Lactobacillus isolates, dominant in healthy women, and common BV species (Atopobium vaginae, Gardnerella vaginalis and Prevotella bivia). METHODS: Colonised epithelia were infected with Trichomonas vaginalis (TV) or exposed to purified TV virulence factors (membrane lipophosphoglycan (LPG), its ceramide-phosphoinositol-glycan core (CPI-GC) or the endosymbiont Trichomonas vaginalis virus (TVV)), followed by assessment of bacterial colony-forming units, the mucosal anti-inflammatory microbicide secretory leucocyte protease inhibitor (SLPI), and chemokines that drive pro-inflammatory, antigen-presenting and T cells. RESULTS: TV reduced colonisation by Lactobacillus but not by BV species, which were found inside epithelial cells. TV increased interleukin (IL)-8 and suppressed SLPI, likely via LPG/CPI-GC, and upregulated IL-8 and RANTES, likely via TVV as suggested by use of purified pathogenic determinants. BV species A vaginae and G vaginalis induced IL-8 and RANTES, and also amplified the pro-inflammatory responses to both LPG/CPI-GC and TVV, whereas P bivia suppressed the TV/TVV-induced chemokines. CONCLUSIONS: These molecular host-parasite-endosymbiont-bacteria interactions explain epidemiological associations and suggest a revised paradigm for restoring vaginal immunity and preventing BV/TV-attributable inflammatory sequelae in women.


Assuntos
Bactérias/imunologia , Células Epiteliais/imunologia , Imunidade Inata , Interações Microbianas , Trichomonas vaginalis/imunologia , Bactérias/patogenicidade , Células Cultivadas , Quimiocinas/metabolismo , Contagem de Colônia Microbiana , Células Epiteliais/microbiologia , Células Epiteliais/parasitologia , Feminino , Humanos , Inibidor Secretado de Peptidases Leucocitárias/metabolismo , Trichomonas vaginalis/patogenicidade
2.
PLoS One ; 7(11): e48418, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23144878

RESUMO

Wide-spread protozoan parasites carry endosymbiotic dsRNA viruses with uncharted implications to the human host. Among them, Trichomonas vaginalis, a parasite adapted to the human genitourinary tract, infects globally ∼250 million each year rendering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV infection and HPV-related cancer. While first-line antibiotic treatment (metronidazole) commonly kills the protozoan pathogen, it fails to improve reproductive outcome. We show that endosymbiotic Trichomonasvirus, highly prevalent in T. vaginalis clinical isolates, is sensed by the human epithelial cells via Toll-like receptor 3, triggering Interferon Regulating Factor -3, interferon type I and proinflammatory cascades previously implicated in preterm birth and HIV-1 susceptibility. Metronidazole treatment amplified these proinflammatory responses. Thus, a new paradigm targeting the protozoan viruses along with the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.


Assuntos
Antiparasitários/farmacologia , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Parasitos/efeitos dos fármacos , Parasitos/virologia , Simbiose/efeitos dos fármacos , Totiviridae/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Feminino , Interações Hospedeiro-Patógeno/imunologia , Humanos , Imunidade Inata/efeitos dos fármacos , Inflamação/patologia , Fator Regulador 3 de Interferon/metabolismo , Metronidazol/farmacologia , Modelos Biológicos , RNA de Cadeia Dupla/metabolismo , Ribonuclease III/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Receptor 3 Toll-Like/metabolismo , Trichomonas vaginalis/efeitos dos fármacos , Trichomonas vaginalis/isolamento & purificação , Trichomonas vaginalis/patogenicidade , Trichomonas vaginalis/virologia , Vagina/imunologia , Vagina/parasitologia , Vagina/patologia , Vagina/virologia , Vírion/efeitos dos fármacos , Viroses/imunologia , Viroses/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA